Indonesia Expat
Featured News

Indonesia COVID-19 Vaccine Update

Indonesia COVID-19 Vaccine Update

It’s been over a month since Sinovac Biotech China started carrying out phase 3 clinical trials in Indonesia of its potential COVID-19 vaccine.

Up to this point, there have been no complications reported among the test subjects.

“Of the 1,620 volunteers who took part in the vaccine trial, none of the individuals has experienced significant side effects,” reported Vensya Sitohand, the Director of Health Surveillance and Quarantine.

Sinovac’s vaccine clinical trials are running in collaboration with Bio Farma and are expected to last seven months. To speed up the distribution of vaccines to the public, Bio Farma is to propose a new vaccine registration process.

“While waiting for the clinical trial to be completed, preparation for vaccine production will start from November to December,” said the Head of Vaccine Research Team from the Faculty of Medicine.

“Currently, our production capacity downstream will mean 250 million doses will be available in 2021, an increase from 100 million doses in 2020. If the clinical trials run smoothly, they will be produced in January 2021,” he concluded.

Source: CNBC Indonesia

Related posts

Minister of Finance Sri Mulyani’s Vision for Secure and Efficient Cross-Border Trade

Indonesia Expat

Collaboration of Fraser Residence Sudirman Jakarta, Fraser Residence Menteng Jakarta, Fraser Place Setiabudi Jakarta and Apartment The Peak at Sudirman Organize Blood Donation Action “Donate Blood, Save Lives”

Indonesia Expat

Australia Urges Free Trade Partnership to Include Education

Nadya Joy Ador

Immigration Office Awaits Approval to Track Foreigners

Indonesia Expat

Odd-Even Policy Revoked

Indonesia Expat

American Gets Life from Indonesian Court for Drug Smuggling

Milafel Dacanay